Signs Agreement With Vetbiolix For Development Of Piclidenoson For Pets
28/06/2021 13:40
June 28 (Reuters) - Can Fite Biopharma Ltd CANF.TA :
* CAN FITE BIOPHARMA LTD - SIGNS AGREEMENT WITH VETBIOLIX
FOR
DEVELOPMENT OF PICLIDENOSON FOR PETS
* CAN FITE BIOPHARMA LTD - ALL PRE-CLINICAL, CLINICAL, AND
REGULATORY DEVELOPMENT WORK TO BE CONDUCTED AND FINANCIALLY
COVERED BY VETBIOLIX
Source text for Eikon: ID:nBw6LZzt2a
Further company coverage: CANF.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Can Fite Biopharma
See all newsBrief: Corrected-Can Fite Biopharma Ltd Files For Offering Of Up To 6.6 mln Ordinary Shares By Selling Shareholders
Can-Fite BioPharma rises after longer-than-anticipated overall survival in ongoing liver cancer study
Can-Fite BioPharma reports longer-than-anticipated overall survival in ongoing liver cancer study
Brief: Can Fite Biopharma Can-Fite Submits Phase 2 Study Protocol For Piclidenoson In Lowe Syndrome
Can-Fite rises as skin drug study reaches interim analysis stage